Pinned post
1/5: Our work in the TOP trial is now in JAMA. TOP randomized 1428 high cardiac risk patients after major general or vascular surgery to a restrictive (Hb < 7 g/dL) or liberal (Hb < 10 g/dL) transfusion strategy. 👇
@AmCollSurgeons @VascularSVS @sunydownstate @ShereneSharath
@AmCollSurgeons @VascularSVS @sunydownstate @ShereneSharath